CA-INGRAM-MICRO
13.3.2019 18:02:11 CET | Business Wire | Press release
INGRAM MICRO CLOUD SUMMIT – Ingram Micro Inc. today announced the next iteration of the Ingram Micro Cloud Marketplace, adding new features, functionality and resources designed to help technology partners and independent software vendors (ISVs) to do more with more. Inspired by partner feedback, the new enhancements streamline and standardize processes, increase efficiencies and effectiveness in sales and marketing, and ultimately will make it easier for technology partners and ISVs to grow their business more profitably using the Ingram Micro Cloud Marketplace.
Among the key enhancements and features readily available today as part of the Ingram Micro Cloud Marketplace are:
Ingram Micro Connect – Powered by CloudBlue, Ingram Micro Connect is an easy-to-use, digital module that provides a fast and cost-effective way to publish, manage and promote cloud services to as many as 200,000 technology partners using Ingram Micro Cloud Marketplace. Ingram Micro Connect simplifies and automates distribution by providing robust publishing tools, digital contracting, multi-marketplace targeting, and sales and marketing content creation tools.
New Customer Experience – A new, modern UI for the Ingram Micro Cloud Marketplace featuring an updated, user-friendly interface that makes it easier for technology partners to find, navigate, and purchase cloud services while streamlining end-customer management.
Sales & Marketing Hub – An industry-first, digital suite for technology partners designed to help educate and enable their salespeople on cloud services while providing pre-built campaign templates and valuable marketing tools to their marketers. The complementary resource provides a single destination to discover and learn about cloud services, create and execute marketing campaigns, and customize sales enablement and access industry insights so they can be the go-to cloud experts for their customers.
Marketplace API – A new API that enables technology partners to quickly integrate their own online storefront, CRM and billing systems into the Ingram Micro Cloud Marketplace. As a result, technology partners using the Cloud Marketplace can now better manage and automate ordering and billing; create and manage customer accounts, users and subscriptions; and retrieve billing data that can be used to bill end customers.
“Ingram Micro has elevated the experience our technology partners and ISVs are having with the Ingram Micro Cloud Marketplace, enabling them simply to do more with more and capitalize on the growing opportunity cloud continues to deliver,” said Tarik Faouzi, Vice President of Cloud Product Management, Ingram Micro. “These enhancements, powered by CloudBlue, all tie to Ingram Micro’s overall vision to provide our partners a hyper-scale digital platform, access to an infinite ecosystem, and proven go-to-market services.”
Ingram Micro’s Cloud Marketplace was first to market in 2009, and is now used by more than 55,000 technology partners worldwide to manage nearly four million fully-automated seats. The Ingram Micro Cloud Marketplace can be found here .
Supporting Partner Quotes and Industry Statistics
“Using Ingram Micro Connect, we’re able to quickly add our cloud
products to the Cloud Marketplace and position them in front of Ingram
Micro’s thousands of resellers with uniform, ready-to-use sales and
marketing resources.”
- Dmitry Leonov, Co-Founder, SaneBox
Channel partners spend up to 40 percent of their time sifting through
content.
- Source: Quotient, “Five Step Guide to Enable Channel
Sale,” May 2016
When enabled, resellers achieve 28 percent shorter sales cycles and a 12
percent higher lead conversion rate.
- Source: Aberdeen Group,
“Territory, Training, Technology: Best-in-Class Channel Sales
Management,” March 2016
A recent study from The 2112 Group notes 73% of MSPs don’t have
marketing plans or programs; 52% of partners say they’re expanding sales
and marketing efforts of existing products and services to grow their
business in 2019.
- Source: The 2112 Group, “2017 State of the
U.S. Cloud Channel Report”
“The Sales & Marketing Hub helps significantly reduce the time it takes
us to learn about vendor products and create the sales and marketing
assets that go along with them. Plus, we now have access to a library of
research on cloud business strategies and industry news that will help
us develop more effective strategies for our cloud business. GetBEE
looks forward to growing on the Sales & Marketing Hub with Ingram Micro.”
-
Thea Myhrvold, Founder and CEO, GetBEE
“Together, these new additions to the Cloud Marketplace will enable our
technology vendor partners to automate more processes and, as a result,
not only operate more efficiently to increase profits, but also to
expand their market footprint, and enable our reseller partners to
monetize an ever larger pool of anything as a service.”
- David
Wippich, CTO and Senior Vice President, Global Cloud, Ingram Micro
About Ingram Micro Cloud
At Ingram Micro Cloud,™ we view cloud not just as a single technology, but as a foundational platform to run and drive a whole new way of doing business. By leveraging our platforms and ecosystem, cloud service providers, telecom companies, resellers and enterprises can quickly transform and get up and running in the cloud within minutes, with little to no investment. Our portfolio includes vetted security, communication and collaboration, business applications, cloud management services and infrastructure solutions designed to help clients monetize and manage the entire lifecycle of cloud and digital services, infrastructure and IoT subscriptions. For more information, please visit: www.IngramMicroCloud.com .
About Ingram Micro Inc.
Ingram Micro helps businesses Realize the Promise of Technology ™. It delivers a full spectrum of global technology and supply chain services to businesses around the world. Deep expertise in technology solutions, mobility, cloud, and supply chain solutions enables its business partners to operate efficiently and successfully in the markets they serve. Unrivaled agility, deep market insights and the trust and dependability that come from decades of proven relationships, set Ingram Micro apart and ahead. More at www.ingrammicro.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190313005555/en/
Contact:
Global Media Contact: Marie Rourke WhiteFox Marketing Inc. (for CloudBlue and Ingram Micro) 714-292-2199 marie@whitefoxpr.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom